HZNP - Horizon Therapeutics gains after FTC settles with Amgen over $28B deal
2023-09-01 08:53:19 ET
More on Amgen, Horizon Therapeutics, etc.
- Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?
- Improved Outlook For Horizon Therapeutics And Amgen
- Amgen Is Back!
- Amgen Gives You Growth, Dividend Growth, And Value
- Amgen Inc. 2023 Q2 - Results - Earnings Call Presentation
- Amgen Inc. ( AMGN ) Q2 2023 Earnings Call Transcript
- Amgen: Huge Potential With Biosimilars And GLP-1
- Amgen: Is The 3.79% Dividend Yield Worth The Fuss?
- Court hearing on FTC's challenge to Horizon/Amgen rescheduled until next week
- Biggest stock movers today: Hawaiian Electric, RPT Realty, VinFast Auto and more
- Amgen could reach settlement with FTC over Horizon in next few weeks - report
- Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks
- Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)
- Horizon Therapeutics gains as FTC withdraws in-house trial on Amgen deal
- FTC likely to lose its challenge to the Horizon/Amgen deal, legal experts say - analyst
- Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen
For further details see:
Horizon Therapeutics gains after FTC settles with Amgen over $28B deal